Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 7:28 AM

Published 11/07/2009 by Minneapolis Star Tribune


Boston Sci settles implant recall case

Boston Scientific Corp. said Friday it has reached a $296 million agreement with the U.S. Department of Justice related to a series of product recalls in 2005, ending a wrenching chapter in medical technology that has lingered for more than four years.

In an investigation...

Share this 

What others report on the same story

Boston Scientific Sets $296 Million Settlement ...
Now you see it. Now you don’t. So it goes with Boston Scientific’s third-quarter profit as a result of a settlement agreement with the Justice Department that the ... - [11/06/2009 - WSJ.com: Health Blog]

Quotes

...office, said "an agreement has been reached in principle; formal documents will be filed and made public in the next few weeks." Boston Scientific said...
...a statement that "Guidant and its employees acted in good faith and believed they complied with applicable laws and regulations." The company opted to...
...effort to devote "our full energies and resources to developing our innovative technologies." (The company's Arden...

Related Stories

First Reported 11/14/2009 - Updated 11/14/2009 - 4 Documents (in Health)
Anheuser-Busch Companies Inc - Click to view image in its original context
Anheuser-Busch Companies Inc
The US Food and Drug Administration (FDA) Friday notified some 30 drinks manufacturers who combine alcohol and caffeine in their beverages that they must prove the products are safe."The increased popularity of consumption of caffeinated alcoholic beverages ... [MedIndia - 11/14/2009]
First Reported 11/06/2009 - Updated 11/07/2009 - 11 Documents
Guidant Corporation - Click to view image in its original context
Guidant Corporation
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales ... [News-Medical.Net - 11/07/2009]
First Reported 11/02/2009 - Updated 11/02/2009 - 8 Documents (in Internet & IT)
Boston Scientific Corporation - Click to view image in its original context
Boston Scientific Corporation
Boston Scientific Corporation Monday announced it hasreceived CE Mark for its PROMUS Element Everolimus-Eluting Coronary Stent System, the Company’sthird-generation drug-eluting stent technology. ... [FDA News - 11/02/2009]
First Reported 11/12/2009 - Updated 11/13/2009 - 5 Documents (in Health)
WASHINGTON (Reuters) - U.S. health regulators requested information from nearly 30 makers of caffeinated alcoholic beverages on why they believe their products are safe. ... [Reuters: U.S. - 11/13/2009]
First Reported 11/06/2009 - Updated 11/07/2009 - 7 Documents (in Health)
The U.S. Food and Drug Administration is enforcing the flavored cigarette ban provision of the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) by issuing several warning letters to companies continuing to sell illegal flavored ... [Red Orbit - 11/07/2009]
First Reported 11/02/2009 - Updated 11/02/2009 - 2 Documents (in Health)
Food and Drug Administration - Click to view 360-page
Food and Drug Administration
Treasury prices tumbled Monday, pushing their yields higher, as stronger-than-expected reports on manufacturing and housing allay some concerns about the strength of the U.S. economic ... ... [SignOn San Diego - 11/02/2009]
First Reported 11/04/2009 - Updated 11/04/2009 - 1 Documents (in Health)
NEW YORK, Nov 4 (Reuters) - Shares of GenVec Inc rose 30 percent to $1.04 in premarket trading on Wednesday, after the company's experimental cancer drug got an orphan drug designation from the Food and Drug Administration.For details, see(Reporting by ... [Forbes.com - 11/04/2009]
First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents (in Health)
NEW YORK, Nov 5 (Reuters) - Shares of Sunesis Pharmaceuticals rose 45 percent to 55 cents in premarket trading on Thursday, after the company said one of its drugs had received orphan drug designation from the Food and Drug Administration.(Reporting by ... [Forbes.com - 11/05/2009]
First Reported 11/10/2009 - Updated 11/10/2009 - 1 Documents (in Health)
The U.S. Food and Drug Administration says it has approved a new treatment for patients with a rare form of cancer known as Cutaneous T-cell Lymphoma.The FDA says it has approved the use of Istodax (romidepsin), an injectable medication for the slow-growing ... [Pharmacy Choice - 11/10/2009]
First Reported 11/10/2009 - Updated 11/10/2009 - 1 Documents (in Health)
SILVER SPRING, Md., Nov. 10 /PRNewswire-USNewswire/ -- Dr. Margaret Hamburg, Commissioner of Food and Drugs, today sent a letter to America's doctors, thanking them for their efforts during the 2009 H1N1 influenza outbreak and providing information on ... [Stockwatch - 11/10/2009]
First Reported 11/12/2009 - Updated 11/12/2009 - 1 Documents (in Health)
Media Inquires: Patricia El-Hinnawy, 301-796-4763; patricia.el-hinnawy@fda.hhs.govConsumer Inquiries: 888-INFO-FDAFDA Commissioner Addresses Nation's Healthcare Professionals on H1N1 VaccineDr. Margaret Hamburg, Commissioner of Food and Drugs, today sent ... [U.S. Food and Drug Administration - 11/12/2009]
First Reported 10/31/2009 - Updated 10/31/2009 - 1 Documents (in Health)
Company: Procter & Gamble Co. (The) (PG)FDA NEWS RELEASE FDA: Procter & Gamble Unlawfully Marketing Two Vicks Cold and Flu Medicines Containing Vitamin CThe U.S. Food and Drug Administration today sent a warning letter to Procter & Gamble notifying the ... [Zibb - 10/31/2009]
Network

Blogs

sort by: Date | Relevance
Boston Scientific Sets $296 Million Settlement ... [WSJ.com: Health Blog - 11/06/2009]
Now you see it. Now you don’t. So it goes with Boston Scientific’s third-quarter profit as a result of a settlement agreement with the Justice Department that the ...
FDA Social Media Guidelines Best Done in Baby S... [Pharma Marketing Blog - 11/14/2009]
In his closing remarks at yesterday's public hearing on FDA regulation of social media, Tom Abrams, Director of FDA's Division of Drug Marketing, Advertising, and ...
FDA Social Media Hearing Day 1: My Key Takeaways [Pharma Marketing Blog - 11/13/2009]
In my presentation before the FDA at yesterday's public hearing, I made some specific suggestions, including the use of an FDA-designated hash tag to be included ...
Fun With the Minneapolis Mayoral Race [Boing Boing - 11/03/2009]
I pulled up my sample ballot for Minneapolis elections today, and found something absolutely fabulous. Take a look at the second-from-last candidate. Specifically, ...
FDA warns companies not to sell flavored cigare... [Business - cleveland.com - 11/06/2009]
The FDA banned candy-, fruit- and clove-flavored cigarettes in September. Federal health authorities and regulators say those products appeal especially ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Raw Deal [Slate Magazine - 11/11/2009]
H1N1 hits Boston minorities [CNN.com - Video - 11/13/2009]
FDA's "Plan B" decision [Rep. Mark Souder - YouTube Channel - 11/12/2009]
Boston woman's near miss on subway [Reuters Video: Top News - 11/10/2009]
Sen. Landrieu on proposed FDA oyster ban [Senator Mary L Landrieu - YouTube Channel - 11/10/2009]
1 2 3 4

  •  
  •  
  •